Athersys Inc (ATHX.OQ) Quote| Reuters.com
Edition:
United States

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.97USD
24 Jun 2016
Change (% chg)

$-0.04 (-1.75%)
Prev Close
$2.00
Open
$2.00
Day's High
$2.00
Day's Low
$1.80
Volume
5,569,675
Avg. Vol
184,275
52-wk High
$2.89
52-wk Low
$0.94

ATHX.OQ

Chart for ATHX.OQ

About

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating... (more)

Overall

Beta: 0.23
Market Cap(Mil.): $165.78
Shares Outstanding(Mil.): 84.36
Dividend: --
Yield (%): --

Financials

  ATHX.OQ Industry Sector
P/E (TTM): 215.93 38.82 34.11
EPS (TTM): 0.01 -- --
ROI: 2.98 -5.72 14.23
ROE: 3.64 -4.83 15.46

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.